U-Blot® Research Grade OmodenbamabCat. No. WA3280Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade OmodenbamabCat. No. WA3280U-Blot® Research Grade omectatugCat. No. WA3279Request quote
Size: 50ug/100ug
U-Blot® Research Grade OmburtamabCat. No. WA3278Request quote
Size: 50ug/100ug
U-Blot® Research Grade ombetoxabartCat. No. WA3277Request quote
Size: 50ug/100ug
U-Blot® Research Grade OmalizumabCat. No. WA3276Request quote
Size: 50ug/100ug
U-Blot® Research Grade olsutamigCat. No. WA3275Request quote
Size: 50ug/100ug
U-Blot® Research Grade OlokizumabCat. No. WA3274Request quote
Size: 50ug/100ug
U-Blot® Research Grade OloctinebartCat. No. WA3273Request quote
Size: 50ug/100ug
U-Blot® Research Grade OlinvacimabCat. No. WA3272Request quote
Size: 50ug/100ug
U-Blot® Research Grade OlintatugCat. No. WA3271Request quote
Size: 50ug/100ug
U-Blot® Research Grade olevaprubartCat. No. WA3270Request quote
Size: 50ug/100ug
U-Blot® Research Grade OlendalizumabCat. No. WA3269Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598